Followers | 118 |
Posts | 7495 |
Boards Moderated | 0 |
Alias Born | 03/22/2014 |
Tuesday, November 03, 2015 6:55:19 AM
UGAZ rolls into the January contract starting this Friday and is completely into January contract by the 13 of November. UNG contract roll December-->January starts on November 16 and finishes on the 19th (4 day roll starting 2 weeks before December contract expiry).
To avoid contango in both, I will wait to buy until each are fully in the January contract since Feb. contract is trading about the same and there is much less contango than there was going November-->Dec.
I will put 1/2 my money designated for natgas trade in UNG for a ~2 month hold starting around November 20 and complete loading UNG by end of November.
I will cover my UGAZ short sometime next week (after UGAZ rolls into January). I will put 25% of my NG money into a core UGAZ position starting either 2nd or 3rd week of November depending on price action and swing trade the other 25%, sometimes hedging using DGAZ or shorting UGAZ in order to capture more gains.
I will keep an additional 25% to supplement my swing trade in case I need to average down and also do the same with UNG core. (so normally I'll have 100% of NG money invested and if there is a surprise drop I'll put another 50% in, half into UNG and half into the swing trade to average down).
That is my plan.
Happy trading and good luck to everyone. Let's make some money!
Stop swinging for the fences and start playing the swings.
Recent UNG News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 10:18:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:26:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 03:59:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 01:30:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:32:46 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/04/2023 10:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 03:11:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:02:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 04:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 11:39:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 01:17:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 11:42:02 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/08/2023 08:34:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:31:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 02:29:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 02:02:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:12:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM